510(k) · Cleared
ClearedAlma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Alma Lasers, Inc. · GEX Powered Laser Surgical Instrument
Cleared on Sep 24, 2025 as substantially equivalent to K103501 (Alma Lasers, Inc., 2011) after a 257-day review. Its family tree reaches back 9 generations to 1994.
- Decided
- Sep 24, 2025
- Review
- 257 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 9 generations to K936109 (1994). 30 ancestors in all, the oldest K822136 (1982). No later device cites it as a predicate yet.
- Root · 9 generations backK936109 Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc. · 1994
- 5 generations between
- 3 generations backK040234 Laserpro CO2 Carbon Dioxide Laser SystemPhoto Medex, Inc. · 2004
- 2 generations backK080463 Alma Lasers Thermoxel CO2 Laser System and Delivery Device AccessoriesAlma Lasers, Ltd. · 2008
- 1 generation backK103501 Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesAlma Lasers, Inc. · 2011
- This deviceK250071 Alma FemiLift Pixel CO2 Laser System, Delivery Devices and AccessoriesAlma Lasers, Inc. · 2025
Show all 9 generations
- Root · 9 generations backK936109 Sharplan Model 1120 CO2 Surgical LaserSharplan Lasers, Inc. · 1994
- 8 generations backK960521 Sharplan Lasers, Inc. Silktouch Flash ScannerSharplan Lasers, Inc. · 1996
- 7 generations backK963339 Coherent Ultrapulse CO2 Surgical LasersCoherent Medical Group · 1997
- 6 generations backK974789 Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and LLumenis, Inc. · 1998
- 5 generations backK022060 Lumenis Ultrapulse Encore Carbon Dioxide Surgical Lasers and…Lumenis, Inc. · 2002
- 4 generations backK030147 Lumenis Family of Ultrapulse Surgitouch CO2 Surgical LasersLumenis, Ltd. · 2003
- 3 generations backK040234 Laserpro CO2 Carbon Dioxide Laser SystemPhoto Medex, Inc. · 2004
- 2 generations backK080463 Alma Lasers Thermoxel CO2 Laser System and Delivery Device AccessoriesAlma Lasers, Ltd. · 2008
- 1 generation backK103501 Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesAlma Lasers, Inc. · 2011
- This deviceK250071 Alma FemiLift Pixel CO2 Laser System, Delivery Devices and AccessoriesAlma Lasers, Inc. · 2025
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −9 | K936109 | Sharplan Model 1120 CO2 Surgical Laser | Sharplan Lasers, Inc. | 1994 | — |
| −8 | K960521 | Sharplan Lasers, Inc. Silktouch Flash Scanner | Sharplan Lasers, Inc. | 1996 | — |
| −7 | K963339 | Coherent Ultrapulse CO2 Surgical Lasers | Coherent Medical Group | 1997 | — |
| −6 | K974789 | Coherent Ultrapulse S Series CO2 Surgical Lasers Model C and L | Lumenis, Inc. | 1998 | — |
| −5 | K022060 | Lumenis Ultrapulse Encore Carbon Dioxide Surgical Lasers and Delivery Device… | Lumenis, Inc. | 2002 | — |
| −4 | K030147 | Lumenis Family of Ultrapulse Surgitouch CO2 Surgical Lasers | Lumenis, Ltd. | 2003 | — |
| −3 | K040234 | Laserpro CO2 Carbon Dioxide Laser System | Photo Medex, Inc. | 2004 | — |
| −2 | K080463 | Alma Lasers Thermoxel CO2 Laser System and Delivery Device Accessories | Alma Lasers, Ltd. | 2008 | — |
| −1 | K103501 | Alma Lasers Pixel CO2 Laser System, Delivery Device and Accessories | Alma Lasers, Inc. | 2011 | — |
| 0 (this device) | K250071 | Alma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories | Alma Lasers, Inc. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1982 | 1 | 0 |
| 1986 | 1 | 0 |
| 1988 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2007 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K103501 | Alma Lasers Pixel CO2 Laser System, Delivery Device and AccessoriesSummary page 9…Classification Regulation: 21 CFR 878.4810 Product Code: GEX Predicate Device Alma Lasers Pixel CO2 Laser System, Delivery Device and Accessories (K103501) Device Description The Alma FemiLift Pixel CO2 System is a laser system designed to deliver light energy for use i… | 2011 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 31 years and passes through 7 companies; a new generation was cleared every 1.9 years on median.
- None of the 30 ancestors has a recall.
- 4 other devices also cite its predicate K103501.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The Alma FemiLift Pixel CO2 Laser System and Delivery Device Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).The Alma FemiLift Pixel CO2 Laser System is cleared for use for the particular…
Read the full statement (1,228 words)
The Alma FemiLift Pixel CO2 Laser System and Delivery Device Accessories are intended for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: aesthetic surgery (dermatology and plastic surgery), podiatry, gynecology, neurosurgery, orthopedics (soft tissue), arthroscopy (knee).The Alma FemiLift Pixel CO2 Laser System is cleared for use for the particular indications as follows:
Dermatology & Plastic Surgery
The ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery in the performance of:
• Laser skin resurfacing
• Laser dermabrasion
• Laser burn debridement.
Laser skin resurfacing (ablation and/or vaporization) for the treatment of:
• Wrinkles, rhytids, and furrows (including fines lines and texture irregularities)
Clinical literature demonstrates that skin resurfacing of wrinkles, rhytids, and furrows with CO2 laser increases the amount of sub-epidermal collagen.
Laser skin resurfacing (ablation and/or vaporization) of soft tissue for the reduction, removal, and/or treatment of:
• Keratoses, including actinic and seborrheic keratosis, seborrheic vulgaris, seborrheic wart, and verruca seborrhoica;
• Vermilionectomy of the lip;
• Cutaneous horns;
• Solar/actinic elastosis;
• Cheilitis, including actinic cheilitis;
• Lentigines, including lentigo maligna or Hutchinson’s malignant freckle;
• Uneven pigmentation/ dyschromia;
• Acne scars;
• Surgical scars;
• Keloids including acne keloidalis nuchae;
• Hemangiomas (including Buccal, port wine and pyogenic granulomas/granuloma pyogenicum/granuloma telagiectaticum);
• Tattoos;
• Telangiectasia;
• Removal of small skin tumors, including periungual (Koenen) and subungual fibromas;
• Superficial pigmented lesions;
• Aden sebaceous hypertrophy or sebaceous hyperplasia;
• Rhinophyma reduction;
• Cutaneous papilloma (skin tags);
• Milia;
• Debridement of eczematous or infected skin;
• Basal and squamous cell carcinoma, including keratoacanthomas, Bowen's disease (Erythroplasia of Queyrat), and Bowenoid Papulosis (BP) lesions;
• Nevi, including spider, epidermal and protruding;
• Neurofibromas;
• Laser de-epithelialization;
• Trichoepitheliomas;
• Xanthelasma Palpebrarum;
• Syringoma
Laser ablation, vaporization and /or excision for complete or partial nail matrixectomy.
Vaporization/coagulation of:
• Benign/malignant vascular/avascular skin lesions;
• Moh’s Surgery;
• Lipectomy;
• Verrucae and seborrheic vulgaris, including paronychial, perifungal, and subungual warts.
Laser incision and /or excision of soft tissue for the performance of upper and lower eyelid blepharoplasty.
Laser incision and /or excision of soft tissue for the creation of recipient sites for hair transplantation.
Laser incision and /or excision of soft tissue for the performance of upper and lower eyelid blepharoplasty.
Laser incision and /or excision of soft tissue for the creation of recipient sites for hair transplantation.
Podiatry
Laser ablation, vaporization and /or excision of soft tissue for the reduction, removal, and/or treatment of:
• Verrucae vulgaris/plantar (warts), including paronychial, perifungal, and subungual warts;
• Fungal nail treatment;
• Porokeratoma ablation;
• Ingrown nail treatment;
• Neuromas/fibromas, including Morton's neuroma;
• Debridement of ulcers;
• Other soft tissue lesions.
Laser ablation, vaporization and /or excision in podiatry for complete or partial matrixectomy.
Otolaryngology (ENT)
Laser incision, excision, ablation and/or vaporization of soft tissue in otolaryngology the treatment of:
• Choanal atresia,
• Leukoplakia, including oral, larynx, uvula, palatal, upper lateral pharyngeal tissue;
• Nasal obstruction;
• Adult and juvenile papillomatosis polyps;
• Polypectomy of nose and nasal passages;
• Lymphangioma removal;
• Removal of vocal cord/fold nodules, polyps and cysts;
• Removal of recurrent papillomas in the oral cavity, nasal cavity, larynx, pharynx and trachea, including the uvula, palatal, upper lateral pharyngeal tissue, tongue and vocal cords;
• Laser/tumor surgery in the larynx, pharynx, nasal, ear and oral structure and tissue
• Zenker’s Diverticulum/pharyngoesophageal diverticulum [endoscopic laser-assisted esophageal diverticulectomy (ELAED)];
• Stenosis, including subglottic stenosis; tonsillectomy (including tonsillar cryptolysis, neoplasma) and tonsil ablation/tonsillotomy;
• Pulmonary bronchial and tracheal lesion removal;
• Benign and malignant nodules, tumors and fibromas (larynx, pharynx, trachea, tracheobronchial/endobronchial);
• Benign and malignant lesions and fibromas (nose and nasal passages);
• Benign and malignant tumors and fibromas; (oral);
• Stapedotomy/stapedectomy;
• Acoustic neuroma in the ear;
• Superficial lesions of the ear, including chondrodermatitis nondularis chronica helices/Winkler’s disease;
• Telangiectasia/hemangioma of larynx, pharynx and trachea (includes uvula, palatal or upper lateral pharyngeal tissue);
• Cordectomy, cordotomy (for the treatment of vocal fold paralysis/vocal fold motion impairment), and cordal lesions of larynx, pharynx and trachea;
• Myringotomy/tympanostomy (tympanic membrane fenestration);
• Uvulopalatoplasty (LAUP, laser UPPP);
• Turbinectomy and turbinate reduction/ablation);
• Septal spur ablation/reduction and septoplasty;
• Partial glossectomy;
• Tumor resection on oral, subfascial and neck tissues;
• Rhinophyma;
• Verrucae vulgaris (warts);
• Gingivoplasty/gingivectomy.
Gynecology (GYN)
Laser incision, excision, ablation and/or vaporization and of soft tissue in gynecology (GYN) for the treatment of:
• Conization of the cervix, including cervical intraepithelial neoplasia (CIN), vulvar and vaginal intraepithelial neoplasia (VIN, VAIN);
• Condyloma acuminate, including cervical, genital, vulvar, perineal, and Bowen’s disease, (Erythroplasia of Queyrat) and Bowenoid papulosis (BP) lesions;
• Leukoplakia (vulvar dystrophies);
• Incision and drainage (I&D) of Bartholin’s and Nabothian cysts;
• Herpes vaporization;
• Urethral caruncle vaporization;
• Cervical dysplasia;
• Benign and malignant tumors;
• Hemangiomas.
GYN Laparoscopy
Vaporization, incision, excision, ablation, or photocoagulation of soft tissue in endoscopic and laparoscopic surgery, including GYN laparoscopy, for treatment of:
• Endometrial lesions, including ablation of endometriosis;
• Excision/lysis of adhesions;
• Salpingostomy
• Oophorectomy/ovariectomy;
• Fimbrioplasty;
• Metroplasty;
• Microsurgery (tubal);
• Uterine myomas and fibroids;
• Ovarian fibromas and follicle cysts;
• Uterosacral ligament ablation;
• Hysterectomy.
Neurosurgery
Laser incision, excision, ablation and/or vaporization and of soft tissue in neurosurgery for the treatment of:
Cranial
• Posterior fossa tumors;
• Peripheral neurectomy;
• Benign and malignant tumors and cysts (e.g. gliomas, meningiomas (including basal tumors), acoustic neuromas, lipomas and large tumors);
• Arteriovenous malformation;
• Pituitary gland tumors (transsphenoidal approach).
Spinal Cord
• Incision/excision and vaporization of benign and malignant tumors and cysts;
• Intra- and extradural lesions;
• Laminectomy/ laminotomy/ microdiscectomy.
Orthopedics
Incision/excision and vaporization and of soft tissue in orthopedic surgery. Applications include:
Arthroscopy
• Meniscectomy;
• Chondromalacia;
• Chondroplasty;
• Ligament release (lateral and other);
• Excision of plica;
• Partial synovectomy.
General
• Debridement of traumatic wounds;
• Debridement of decubitus and diabetic ulcers;
• Microsurgery;
• Artificial joint revision;
• PMMA removal.
General/Thoracic Surgery
Incision, excision and vaporization and of soft tissue in general and thoracic surgery including endoscopic and open procedures. Applications include:
• Debridement of decubitus ulcers, stasis, diabetic and other ulcers;
• Mastectomy;
• Debridement of burns;
• Rectal and anal hemorrhoidectomy;
• Breast biopsy;
• Reduction mammoplasty;
• Cytoreduction for metastatic disease;
• Laparotomy and laparoscopic applications;
• Mediastinal and thoracic lesions and abnormalities;
• Skin tag vaporization;
• Atheroma;
• Cysts, including sebaceous cysts, pilar cysts, and mucous cysts of the lips;
• Pilonidal cyst removal and repair;
• Abscesses;
• Other soft tissue applications.
Dental/Oral Surgery
Incision/excision and vaporization of soft tissue in dentistry and oral surgery. Applications include:
• Gingivectomy- removal of hyperplasia;
• Gingivoplasty;
• Incisional and excisional biopsy;
• Treatment of ulcerous lesions, including aphthous ulcers;
• Incision of infection when used with antibiotic therapy;
• Frenectomy (frenum release);
• Excision and ablation of benign and malignant lesions;
• Homeostasis;
• Operculectomy;
• Crown lengthening;
• Removal of soft tissue, cysts and tumors;
• Oral cavity tumors and hemangiomas;
• Abscesses;
• Extraction site hemostasis;
• Salivary gland pathologies;
• Pre-prosthetic gum preparation;
• Leukoplakia;
• Partial glossectomy;
• Periodontal gum resection.
Genitourinary
Incision/excision and vaporization and of soft tissue in genitourinary procedures. Applications include:
• Benign and malignant lesions of external genitalia;
• Condyloma;
• Phimosis
• Erythroplasia
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K250071 · printed Nov 3, 2026
Cite this page
510(k) Report. “K250071: Alma FemiLift Pixel CO2 Laser System, Delivery Devices and Accessories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K250071
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026